Webcast

Part 1: Screening and Interpreting Hepatitis B Serologic Results to Inform Treatment Decisions

Launch Date
09/27/2021
Credit Amount
0.00 Expired
Credit Expires
09/27/2022

Faculty

Kimberly A. Forde, MD, PhD, MHS
Associate Professor of Medicine, Section of Hepatology, Department of Medicine
Temple University Hospital, Lewis Katz School of Medicine, Philadelphia, PA
Kimberly A. Forde, MD, PhD, MHS

Kimberly A. Forde, MD, PhD, MHS, is an Associate Professor of Medicine, in the Section of Hepatology, Department of Medicine, at the Temple University Hospital, Lewis Katz School of Medicine. Dr. Forde earned her Bachelor of Arts degree in Biology from Barnard College and her medical degree from Columbia University, College of Physicians and Surgeons. She completed her Internal Medicine Residency at New York Presbyterian Hospital (Columbia University), with subspecialty training in Gastroenterology and Hepatology, at the University of Pennsylvania where she also served as Chief Fellow. Dr. Forde’s research interests include the epidemiology of viral hepatitis and outcome assessment in patients with acute and chronic liver failure. Dr. Forde is a prolific writer, having authored more than 70 peer reviewed articles in high impact journals such as the New England Journal of Medicine, Gastroenterology and Hepatology. In addition to her research and teaching, she has served on several national committees, including the Clinical Research Committee of the American Association for the Study of Liver Diseases and the nominating Committee for the American Gastroenterological Society.

Lauren M. Hynicka, PharmD, BCPS
Associate Professor of Pharmacotherapy, University of Maryland School of Pharmacy, Baltimore, MD
Lauren M. Hynicka, PharmD, BCPS

Dr. Hynicka is an associate professor of pharmacotherapy at the University of Maryland School of Pharmacy. She served as a clinical pharmacy specialist on a general internal medicine team at the University of Maryland Medical Center for six years before transitioning into her current role, where she manages the treatment of HCV patients in an ambulatory clinic. Her teaching, research, and patient care activities focus on the care of patients with chronic liver diseases including; viral hepatitis B and C and nonalcoholic fatty liver disease. Recent areas of research include streamlining the prior authorization process for HCV medications at a large academic health system, evaluating HCV treatment interruptions, and evaluating the uptake of the 8-week Harvoni medication regimen.

Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Obtaining Credits

Statement of Need

The burden of disease associated with hepatitis B virus (HBV) infection is significant. The statistics are staggering, as a broad cohort of individuals remain undiagnosed, not immunized, and untreated. Addressing the gaps in screening, treating, and monitoring requires active engagement from all members of the health care team—primary care providers, specialists, advanced practice professionals, nurses, and pharmacists. In their role as teachers, advisors, watchdogs, and “nudges,” pharmacists must be prepared for questions from patients and communication with providers.

This CMEO webcast features expert faculty discussing the ways pharmacists can best engage with at-risk patients to promote screening for HBV.

Learning Objectives

At the end of this CME/CE activity, participants should be able to initiate discussions with at-risk patients to promote screening for HBV in the primary care setting.

Financial Support

Supported by an educational grant from Gilead Sciences, Inc.

Target Audience

Pharmacists

Credit Information

Pharmacists/Pharmacy Tech (ACPE) 0.75

This application-based activity is approved for 0.75 contact hour (0.075 CEUs) of continuing pharmacy credit.
JA0007185-0000-21-145-H01-P

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Forde has no disclosures to report.

Dr. Hynicka has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff; no disclosures to report:

  • Maria Glukhovsky, PharmD (planning committee)
  • Jan Perez (planning committee)
  • Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credits

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit https://www.cmeoutfitters.com/privacy-and-confidentiality-policy.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

Part 1: Screening and Interpreting Hepatitis B Serologic Results to Inform Treatment Decisions
Event Date: 09/27/2021